Immunotherapy Weekly articles from November 2004

Immunotherapy Weekly archives from November 2004

Allergen immunotherapy reviewed.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Researchers review allergen immunotherapy in a recent issue of American Family Physician. According to recent research from the United States, "Allergen immunotherapy (also called allergy vaccine...

Glucuronoxylomannan exhibits anti-inflammatory effects in arthritis.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Glucuronoxylomannan exhibits anti-inflammatory effects in collagen-induced arthritis. "This investigation was planned to assess the therapeutic efficacy of glucuronoxylomannan (GXM) in...

ERT can restore impaired immune response in postmenopausal women.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Based on a study in women who'd undergone surgical menopause, researchers in Turkey say estrogen replacement therapy can restore impaired immune response caused by hormone deficiency in postmenopausal...

Energetic and nutritional regulation of immune response reviewed.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Scientists review energetic and nutritional regulation of the adaptive immune response and trade-offs in ecological immunology in a recent issue of the American Journal of Human Biology. ...

Immune therapy appears to reduce risk of second attack of MS.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Intravenous immunoglobulin therapy may reduce the risk of a second attack of symptoms related to multiple sclerosis, according to new research. Multiple sclerosis (MS) is a chronic, inflammatory...

HIV-1 superinfections assessed by autologous heteroduplex mobility.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Scientists have assessed HIV-1 superinfections in a cohort of commercial sex workers in Burkina Faso by an autologous heteroduplex mobility procedure. In a recently published article, scientists in...

HIV-1 immunogen vaccine plus antiretrovirals promotes virologic control.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Therapeutic immunization with an inactivated HIV-1 immunogen plus antiretrovirals promotes virologic control in asymptomatic HIV-infected subjects. According to a study from Spain, "To determine...

Multiresistant Acinetobacter baumannii outbreak occurred in surgical room.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Multi-resistant Acinetobacter baumannii outbreak occurred in a surgical room in Germany. "Outbreaks of Acinetobacter baumannii demonstrating multiple antibiotic resistance, including meropenem...

Phase II study of zileuton for moderate-to-severe acne begins.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Critical Therapeutics, Inc., (CRTX), a biopharmaceutical company focused on the discovery, development, and commercialization of products for respiratory, inflammatory, and critical care diseases,...

Loss of clone with FLT3 gene mutation at relapse does not improve AML prognosis.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- The loss of a clone with an FLT3 gene mutation at relapse does not improve the prognosis of acute myeloid leukemia. According to recent research from Germany, "Internal tandem duplications (ITDs)...

Membrane Cofactor Protein identified as adenovirus receptor.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Membrane Cofactor Protein is identified as the adenovirus receptor. "A tandem mass spectrometry-based approach is demonstrated for detecting a receptor for Ad37, one of the causative agents for...

Study: Anti-dust mite covers effective in reducing allergens.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- A new study provides evidence that people who have allergic asthma and use dust mite-impermeable bed covers have improved peak flow measurements. These findings are featured in the October 2004...

NFAT1 protein assists mast cells with interleukin-13 gene transcription.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- NFAT1 protein assists mast cells with interleukin-13 gene transcription. "Th2 and mast cells are participants in the asthmatic response to allergens, and both cell types produce the cytokines...

Patient knowledge of allergy immunotherapy better than expected.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Patient knowledge of allergy immunotherapy was better than expected. "Immunotherapy is an invaluable therapy for allergic asthma, allergic rhinitis, and hymenoptera hypersensitivity. It is, however,...

Neuronal transport may play a role in neuritic degeneration.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Neuronal transport may play a role in neuritic degeneration. According to a study from the United States, "The presence of amyloid plaques in the brain is one of the pathological hallmarks of...

Pharma company's long-term study of Celebrex expected to continue.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Pfizer Inc. said that three large long-term Celebrex (celecoxib capsules) studies involving more than 6,000 patients have not shown any significant safety issues and are expected to continue to...

Oral fluconazole safe/effective empiric treatment for neutropenic fever.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Oral fluconazole is a safe and effective empiric treatment for persistent neutropenic fever. According to a study from Israel, "Neutropenic patients who continue to be febrile despite adequate...

Antiestrogenic drug combinations may be used for glioblastoma malignancies.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Antiestrogenic drug combinations may be used for glioblastoma malignancies. According to researchers in Turkey, "The antitumor activity of nonsteroidal antiestrogens on C6 and low passage of human...

CD45 plays significant role in nuclear apoptosis by chloride channel regulation.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- CD45 plays a significant role in nuclear apoptosis by chloride channel regulation. According to published research from Canada, "Mitochondrial-perturbating agents such as toxic compounds induce...

Humic acid induces apoptosis in premyelocytic leukemia HL-60 cells.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Humic acid induces apoptosis in promyelocytic leukemia HL-60 cells. According to a study from Taiwan, "It has been shown that humic acid (HA), a phenolic polymer, exhibits pro-oxidant and cytotoxic...

Pharmaceutical company offers its alternative to recalled arthritis medication.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- With the recent recall of the arthritis medication rofecoxib, Boehringer Ingelheim announced that it is supporting patients while they look for new alternatives. The company offered up its own...

Research shows gelatine stimulates synthesis of type II collagen.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Collagen hydrolysate (CH), a special type of gelatine, was shown to stimulate synthesis of type II collagen in a study presented at the annual meeting of the American Society for Bone and Mineral...

Topical medication effective in relieving symptoms of knee osteoarthritis.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Symptoms of primary osteoarthritis of the knee, including pain and stiffness, were significantly improved in patients who used a topical nonsteroidal anti-inflammatory drug (NSAID), according to new...

Bioassay detects soluble MAdCAM-1 in body fluids.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Researchers have developed a bioassay to detect soluble MAdCAM-1 in body fluids. According to recent research from New Zealand, "Mucosal addressin cell adhesion molecule (MAdCAM-1) is a key player...

Data collection complete for phase III Aridol study.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Final patient recruitment for Pharmaxis' phase III trial of Aridol, its asthma management product, was 654 compared with a target of 600, and 616 patients completed the study. Data collection from...

Large study achieves stringent control in formerly uncontrolled asthma.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- A 1-year randomized, stratified double-blind parallel-group study of 3416 patients with uncontrolled asthma showed that the stringent standard of total control was achieved by 41% of all patients from...

Respiratory therapists twice as likely to have asthma as other therapists.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Respiratory therapists are at an increased risk of developing asthma and asthma-related symptoms due to their involvement in the diagnosis and treatment of patients with respiratory conditions. A...

Suite of asthma control and asthma impact surveys launched.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- QualityMetric Incorporated announced launch of a full suite of asthma control and asthma impact surveys for adults and children that measure health-related quality of life (HRQoL) from the patient...

Drug for rheumatism possible boon to heart patients.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Atherosclerosis, which lies behind heart attacks, stroke and other cardiovascular problems, has a major impact on public health. So does chronic rheumatoid arthritis. These two diseases are completely...

Cholesteryl ester transfer protein induces long-lasting antibodies.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Subcutaneous and mucosal administration of a 26-amino acid cholesteryl ester transfer protein (CETP) epitope carried by heat shock protein 65 kDa in the absence of adjuvants induced long-lasting...

Thyroid peroxidase DNA immunization replicates thyroid autoimmunity.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Thyroid peroxidase DNA is superior to protein immunization in replicating human thyroid autoimmunity in HLA-DRB1*0301 (DR3) transgenic mice. "Murine experimental autoimmune thyroiditis (EAT),...

Reassortant influenza vaccines control avian influenza.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Scientists have generated reassortant influenza vaccines by reverse genetics that allows utilization of a Differentiating Infected from Vaccinated Animals (DIVA) strategy for the control of avian...

Allergy academy presents Samter Journalism Awards for health, medical reporting.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- The American Academy of Allergy, Asthma and Immunology (AAAAI) announced the 5th Annual Samter Journalism Award Program. The AAAAI developed the Samter Award to celebrate and award outstanding...

Biotech firm lauds Nobel winner, announces olfactory-based government contract.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Joseph K. Pagano, chairman of the board of Sentigen Holding Corp. (SGHL), a biotechnology company, extended congratulations to Dr. Richard Axel, Sentigen's long term good friend and consultant, on being...

Educators honored for linking hygiene and health.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Programs teaching childcare providers about indoor air quality and improving consumers' food safety and hygiene practices are the recipients of the 2004 Soap and Detergent Association (SDA) "Clean Homes...

Oligonucleotide array technology rapidly detects foodborne pathogenic bacteria.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Oligonucleotide array technology rapidly detects foodborne pathogenic bacteria. According to a study from China, "A rapid and accurate method for detection for common pathogenic bacteria in...

Gli proteins up-regulate expression of basonuclin in basal cell carcinoma.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Gli proteins up-regulate the expression of basonuclin in basal cell carcinoma. "Tumorigenesis is frequently accompanied by enhanced rRNA transcription, but the signaling mechanisms responsible for...

NIH grants awards for the development of human antibody against anthrax.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Medarex (MEDX) announced that it has received two grants from the U.S. National Institute of Allergy and Infectious Diseases (NIAID) to support Medarex's research and development of MDX-1303, a fully...

Androgen receptor expression inversely correlates with pathologic, tumor stage.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Androgjen receptor expression is inversely correlated with pathologic, tumor stage in bladder cancer. Researchers in the United States conducted a study "to evaluate the expression of the androgen...

Interaction of two botulinum subdomains needed to elicit antibodies.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Interaction between the two subdomains of the C-terminal part of the botulinum neurotoxin A is essential for the generation of protective antibodies. According to a study from France, "The botulinum...

Clinical bovine mastitis diagnosed in a Prototheca zopfii outbreak.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Clinical bovine mastitis was diagnosed in a Prototheca zopfii outbreak. According to a study from Brazil, "Biopsy by fine needle aspiration together with microbiological examination and scanning...

Well-differentiated breast tumors have more 16q loss than poorly differentiated.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Well-differentiated breast tumors have more 16q loss than poorly differentiated tumors. According to a study from the Netherlands, "Loss of heterozygosity (LOH) at the long arm of chromosome 16 is a...

Company changes name and prepares for HIV vaccine trial.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Research company Merix Bioscience announced the change of its name to Argos Therapeutics, Inc. Additionally, the company stated that it is preparing for an HIV clinical trial with Argos' proprietary...

DNAPrint genomics to acquire majority ownership in German pharmaceutical company.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- DNAPrint genomics, Inc., (DNAP) has agreed to acquire a 51.77% stake in German pharmaceutical company Biofrontera, AG. DNAPrint simultaneously announced that it has received a commitment from...

University study affirms efficacy of pheromone-based products, company says.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Human Pheromone Sciences, Inc. (EROX) confirmed that an independent study conducted by researchers at the University of California, Berkeley, and published in the journal, Psychoneuroendocrinology,...

Data released on two spectrum selective kinase inhibitors: XL647, XL999.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Exelixis, Inc., (EXEL) released data at the 16th annual meeting of the European Organization for the Research and Treatment of Cancer (EORTC) in Geneva, Switzerland for two of its receptor tyrosine...

Biotech company receives $3 million NCI award for anticancer vaccine protein.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Stellar Biotechnologies, Inc. has been awarded $3 million from the National Cancer Institute of the [U.S.] National Institutes of Health for the development of production methods, quality standards, and...

Chemotherapy after vaccination benefits glioblastoma patients.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Chemotherapy after vaccination was beneficial in glioblastoma multiforme patients. According to recent research published in the journal Clinical Cancer Research, "Although the development of...

Raf kinase expression increases mortality of influenza-infected mice.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Lung-specific expression of active Raf kinase results in increased mortality of influenza A virus-infected mice. According to published research from Germany, "Alterations in signaling via the...

Data on Thelin presented at American College of Rheumatology Meeting.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Encysive Pharmaceuticals (NASDAQ:ENCY) announced that new clinical data on Thelin (sitaxsentan) was presented at the American College of Rheumatology (ACR) Annual Scientific Meeting in San Antonio,...

Absolute guidelines needed for monitoring minimal residual disease in CML.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Absolute guidelines are needed for monitoring minimal residual disease in chronic myeloid leukemia. According to recent review in the journal Hematology, "Detection and monitoring of minimal...

Increased IgE-antibodies to S. aureus enterotoxins studied in COPD patients.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Staphylococcus aureus enterotoxins (SAEs) may play a disease modifying role in patients with COPD. According to a study from Germany, "Recent evidence suggests that Staphylococcus aureus...

David Allen Galbraith, MD, joins board of Hana Biosciences.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Hana Biosciences, Inc., (HNAB), a biopharmaceutical company headquartered in South San Francisco, California, has elected David Allen Galbraith, MD to its board of directors. Galbraith currently is...

ZD9331 has minimal antitumor activity as 2[superscript]nd/3[superscript]rd line colorectal cancer therapy.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- ZD9331 yields minimal antitumor activity as a 2[superscript]nd or 3[superscript]rd line colorectal treatment. "This study investigated the efficacy, and tolerability of ZD9331 as second- or...

SEEK1 polymorphisms not associated with Crohn disease in Newfoundland.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- SEEK1 polymorphisms that are associated with psoriasis are not associated with Crohn disease in Newfoundland. "Crohn's disease (CD) is an inflammatory bowel disease that is likely the result of an...

Mucoid P. aeruginosa lipotoxins underlie inflammation.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Pseudomonal lipotoxins underlie pulmonary inflammation in cystic fibrosis (CF). "The main cause of the high morbidity and mortality" in CF patients "is the progressive lung inflammation associated...

Microneutralization assay using cytomegalovirus strains developed.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Scientists have developed an efficient fluorescence-based microneutralization assay using recombinant human cytomegalovirus strains expressing green fluorescent protein. "MedImmune Vaccines has...

HIV infection increases risk of dental caries in children.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- HIV infection increases the risk of dental caries in children. "The interrelationship of HIV infection, dental caries, and mucosal immune responses remains controversial. In our study population of...

Biopharmaceutical company announces resutls of dermatological disorder trial.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- ProMetic Life Sciences (PLI: TSX) announced the results of two clinical trials designed to demonstrate safety and efficacy of recombinant Alpha 1-Antitrypsin (rAAt in a topical gel formulation). ...

Regulatory T cells and type 1 diabetes reviewed.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Scientists review regulatory T cells and type 1 diabetes in a recent issue of Clinical Immunology. According to a study from the United States, "A resurgent interest in T cells with regulatory...

Japanese supplier launches new subsidiary in the United States.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Cosmo Bio Co., Ltd., a Japanese supplier of reagents, instruments, and software for immunology, gene engineering, tissue culture, biochemistry, and clinical diagnostics, announced the launch of its new...

Life sciences company announces Nanobacteria blood test manufacturing agreement.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Nanobac Life Sciences, Inc., (OTCPK: NNBP) announced the signing of a manufacturing agreement with Medicorp, Inc., for the production of two blood tests for the detection of Nanobacteria. Nanobac...

U.S. NIH grant to fund human asthma testing with Breathmeter.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Ekips Technologies, Inc., has received a $750,000 phase II National Institutes of Health grant from the National Heart Lung and Blood Institute to support clinical studies for obtaining U.S. Food and...

First cough/cold treatment in film form that melts on the tongue to be marketed.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Novartis Consumer Health, Inc. is set to launch the latest innovation in the over-the-counter, multi-symptom cough/cold treatment category: the first systemic medicine in a convenient thin film form...

U.S. FDA approves new and easy way to take ENBREL.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Amgen, Inc., (AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (WYE), announced that the new 50 mg/mL prefilled syringe of Enbrel (etanercept) has been approved by the U.S. Food and Drug...

Novel antiapoptotic protein X-linked IAP antagonists potential cancer therapy.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Novel antiapoptotic protein XIAP antagonists are a potential therapy for cancers overexpressing X-linked IAP. "Inhibitor of apoptosis (IAP) proteins are overexpressed in many cancers and have been...

Novel compounds exhibit antiviral and antitumor effects.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Novel compounds exhibit antiviral and antitumor effect. Novel platinum compounds and antiviral guanosine-type ligands are antiviral/antitumor. According to a study from Italy, "Platinum...

Phase 1 clinical trial for intranasal delivery of antibiotic initiated.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- SinusPharma, Inc., a developer of therapies for chronic rhinosinusitis (CRS), has initiated a phase 1 clinical trial of SPRC-AB01, a formulation of an antibiotic for nasal inhalation. This trial in...

Emerging pathogen suggests amphibian trade should be closely monitored.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- An emerging pathogen in an introduced amphibian species suggests that the amphibian trade should be closely monitored. "Chytridiomycosis is an emerging fungal disease of amphibians responsible for...

Ascorbate-Cu(II) protects CF-1 mice against HSV-2 encephalitis.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Ascorbate-Cu(II) inactivated HSV-2 and protected CF-1 mice against encephalitis. "Ascorbate is an important antioxidant. However, in the presence of transition metals such as Cu(II) or Fe(III), it...

Polymerase inhibitor in encephalomyelitis linked to immunomodulation.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- The therapeutic effects of PJ34 [N-(6-oxo-5,6dihydrophenanthridin-2-yl)-N,N-dimethylacetamide], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are...

Splenic deoxynivalenol-responsive genes identified.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Splenic genes whose expression is altered by the trichothecene mycotoxin deoxynivalenol (DON) have been identified through microarray analysis. According to toxicologists in the United States,...

EBV is integrated between REL and BCL-11A in American Burkitt lymphoma cell line.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Epstein Barr Virus is integrated between REL and BCL-11A in the American Burkitt lymphoma cell line. "Epstein-Barr virus (EBV) initially isolated from the cultured Burkitt lymphoma (BL) cells, is...

High serum SCC Ag predicts poor survival in esophageal cancer with esophagectomy.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Elevated serum levels of squamous cell carcinoma antigen predicts poor survival in advanced esophageal cancer after esophagectomy. According to recent research published in the World Journal of...

Functional human coagulation factor XIII A-domain expressed in plants.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Functional human coagulation factor XIII A-domain was expressed in plants. "Coagulation factor XIII, a zymogen present in blood as a tetrAm (A(2)B(2)) of A- and B-domains, is one of the components...

Biotech company files Canadian preliminary prospectus for common share offering.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Stressgen Biotechnologies (SSB) has filed a Canadian preliminary prospectus pursuant to which it intends to raise US$50 million. Stressgen has entered into an agreement with 2 broker-dealers who...

Biotherapeutics announces third-quarter 2004 results.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Genentech, Inc., (DNA) announced total product sales of $1.0 billion for the third quarter of 2004, a 54% increase over product sales of $654.9 million in the third quarter of 2003. Operating...

Cangene reports earnings of 52 cents per share for fiscal 2004.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Cangene Corp. reported results for the year ended July 31, 2004. Revenues for the year were $156.9 million, down $29.3 million or 16% from fiscal 2003. Revenues were affected by the continued...

Company focused on antibiotic-resistant bacteria closes $1.1M investment round.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- ConjuGon has successfully raised a $1.1 million investment round from angel investors. ConjuGon will use this capital to fund the research and development of biotherapeutics to combat...

Company raises $12 million to fund gene therapy.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- GENETIX Pharmaceuticals, Inc., has completed a $12 million private equity investment round to fund a phase I/II clinical trial of its pioneering LentiGlobin hemoglobin gene therapy for patients with...

Forward Ventures invests in monoclonal antibody startup.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Forward Ventures, a southern California venture fund focused exclusively on the life sciences, announced its participation in the $27.5 million series A financing of Cellective Therapeutics, a North...

Food allergy group calls for standardized guidelines and training in schools.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Findings of a new study, "Impact of Food Allergies on School Nursing Practice," released in the October issue of The Journal of School Nursing support what many in the medical community and educators...

ELISA to detect foot-and-mouth disease virus antibodies developed.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Researchers have developed a biotinylated 3ABC recombinant protein in a solid-phase competitive ELISA for the detection of antibodies against foot-and-mouth disease virus. According to recent...

Expression of 7 ARP2/3 complex genes are decreased in gastric cancer.
November 3, 2004... 2004 NOV 3 - (NewsRx.com & NewsRx.net) -- The expression of 7 ARP2/3 complex genes are decreased in gastric cancers. "The Arp2/3 complex and filamins play important roles in organization of actin cytoskeleton, and thus in cellular...